FrancophonIA/ELRC3.0 huggingface dataset:
English: • Write the date 14 days from today in the space next to “Discard On”.
Slovenian: • v prostor poleg »Zavrzite dne« zapišite datum, ki je 14 dni od danes.
English: • If you are using the pen for the first time, continue to “New Pen Setup &
Slovenian: • Če peresnik uporabljate prvič, nadaljujte na »Priprava novega injekcijskega peresnika in mešanje zdravila« (poglavje B).
English: Read the package leaflet in full before using Natpar.
Slovenian: Pred uporabo zdravila Natpar v celoti preberite navodilo za uporabo.
English: 3 • Pick up the needle and peel the paper tab back from the needle cap (See Figure F).
Slovenian: 3 • Primite iglo in odluščite papirnati jeziček s pokrovčka igle (glejte sliko F).
English: Read the instructions for use provided in the package leaflet before using the reusable pen.
Slovenian: Pred uporabo peresnika za večkratno uporabo preberite priložena navodila za uporabo.
English: • diarrhoea*
Slovenian: • driska*
English: 16 • Squeeze the needle cap and unscrew the needle (See Figure W).
Slovenian: 16 • Pokrovček igle stisnite in odvijte iglo (glejte sliko W).
English: Natpar contains sodium
Slovenian: Zdravilo Natpar vsebuje natrij
English: Pre-dose serum calcium
Slovenian: Raven kalcija v serumu
English: Each pre-filled pen contains 350 micrograms parathyroid hormone (rDNA).
Slovenian: En napolnjen injekcijski peresnik vsebuje 350 mikrogramov paratiroidnega hormona (rDNA).
English: Figure Z
Slovenian: Slika Z
English: Each pre-filled pen contains 1050 micrograms parathyroid hormone (rDNA).
Slovenian: En napolnjen injekcijski peresnik vsebuje 1050 mikrogramov paratiroidnega hormona (rDNA).
English: 7 • With the needle cap pointing straight up, gently move your pen from side to side about 10 times to start dissolving the powder (See Figure H).
Slovenian: 7 • Peresnik približno 10 krat nežno pomaknite v levo in desno, da se prašek raztopi, medtem ko gleda pokrovček igle naravnost navzgor (glejte sliko H).
English: Figure W
Slovenian: Slika W
English: Hypercalcaemia was reported in clinical trials with Natpar.
Slovenian: V kliničnih preskušanjih zdravljenja z zdravilom Natpar so poročali o hiperkalciemiji.
English: In the case of a missed dose, Natpar must be administered as soon as reasonably feasible and additional exogenous sources of calcium and/or active vitamin D must be taken based on symptoms of hypocalcaemia.
Slovenian: Glede na simptome hipokalciemije mora bolnik dodatno vzeti tudi eksogene vire kalcija in/ali aktivnega vitamina D.
English: Initiating Natpar
Slovenian: Začetek zdravljenja z zdravilom Natpar
English: , nausea*,
Slovenian: , navzea*, bruhanje*
English: Pre-dose and in some cases post-dose serum calcium levels must be monitored during treatment with Natpar (see section 4.2).
Slovenian: Med zdravljenjem z zdravilom Natpar je treba spremljati koncentracijo kalcija v serumu pred odmerjanjem in v nekaterih primerih po njem (glejte poglavje 4.2).
English: Hypocalcaemia, a common clinical manifestation of hypoparathyroidism, was reported in clinical trials with Natpar.
Slovenian: V kliničnih preskušanjih zdravljenja z zdravilom Natpar so poročali o hipokalciemiji, ki je pogosta klinična manifestacija hipoparatiroidizma.
English: Figure K
Slovenian: Slika K
English: Renal and urinary disorders hypercalciuria pollakiuria
Slovenian: Bolezni sečil hiperkalciurija*, polakisurija
English: Figure I
Slovenian: Slika I
English: Each pre-filled pen contains 1400 micrograms parathyroid hormone (rDNA).
Slovenian: En napolnjen injekcijski peresnik vsebuje 1400 mikrogramov paratiroidnega hormona (rDNA).
English: In the placebo-controlled study in adults with hypoparathyroidism, the incidence of anti-parathyroid hormone (PTH) antibodies was 8.8% (3/34) and 5.9% (1/17) in patients who received subcutaneous administration of 50 to 100 micrograms Natpar or placebo once daily for 24 weeks, respectively.
Slovenian: V študiji, nadzorovani s placebom, pri odraslih s hipoparatiroidizmom je bila incidenca protiteles proti paratiroidnemu hormonu (PTH) 8,8 % (3/34) pri bolnikih, ki so
English: Each pre-filled pen contains 700 micrograms parathyroid hormone (rDNA).
Slovenian: En napolnjen injekcijski peresnik vsebuje 700 mikrogramov paratiroidnega hormona (rDNA).
English: • Store your pen with the pen cap on.
Slovenian: • Peresnik shranjujte z nameščenim pokrovčkom.
English: Read and understand these Instructions for Use before you start using the Natpar Pre-filled Pen.
Slovenian: Preden začnete uporabljati napolnjeni injekcijski peresnik Natpar, morate prebrati in razumeti ta navodila za uporabo.
English: • Keep the pre-filled pen in the outer carton in order to protect from light.
Slovenian: • Napolnjen injekcijski peresnik shranjujte v škatli za zagotovitev zaščite pred svetlobo.
English: • chest pain
Slovenian: • bolečine v prsnem košu
English: The Instructions for Use of the Natpar Pre-filled Pen are included in 5 sections: A. Getting Started
Slovenian: Navodilo za uporabo napolnjenega injekcijskega peresnika Natpar je razdeljeno na 5 delov: A. Kako začeti B. Priprava novega peresnika in mešanje zdravila C. Dnevno injiciranje D. Shranjevanje zdravila E. Pogosta vprašanja
English: Call Shire at +44 (0)800 055 6614 for help.
Slovenian: Za pomoč pokličite družbo Shire na +44 (0)800 055 6614.
English: No dose adjustment for Natpar is recommended in patients with mild to moderate hepatic impairment.
Slovenian: Pri bolnikih z blago do zmerno okvarjenim delovanjem jeter prilagoditev odmerka zdravila Natpar ni potrebna.
English: - However, your doctor may start you on 25 micrograms per day based on a blood test result.
Slovenian: - Vendar vam lahko zdravnik na podlagi krvne preiskave predpiše začetni odmerek
English: Natpar 75 micrograms/dose
Slovenian: Natpar 75 mikrogramov/odmerek siva oznaka na peresniku
English: Special populations Elderly
Slovenian: Starejši bolniki
English: Each dose contains 100 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 100 mikrogramov paratiroidnega hormona (rDNA) v 71,4 mikrolitra raztopine.
English: You may need to take more calcium supplements if you have signs of low blood calcium; see section 4 for symptoms.
Slovenian: Če imate znake nizke ravni kalcija v krvi, boste morda morali vzeti več kalcijevih dodatkov.
English: Adjust second
Slovenian: Prilagodite pozneje
English: Solvent
Slovenian: SN
English: Each dose contains 25 micrograms parathyroid hormone (rDNA)* in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 25 mikrogramov paratiroidnparatiroidnega hormona (rDNA)* v 71,4 mikrolitra raztopine.
English: Each dose contains 100 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 100 mikrogramov paratiroidnega hormona v 71,4 mikrolitra raztopine.
English: Discuss with your doctor if you want to stop treatment with Natpar.
Slovenian: Če želite prenehati uporabljati zdravilo Natpar, se posvetujte z zdravnikom.
English: Read “Section 7.
Slovenian: Preden uporabite peresnik Natpar, preberite »7.
English: Each pre-filled pen contains 350 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Slovenian: En napolnjen injekcijski peresnik vsebuje 350 mikrogramov paratiroidnega hormona (rDNA) v obliki praška v prvi komori in 1000 mikrolitrov vehikla v drugi komori (kar ustreza 14 odmerkom).
English: Each pre-filled pen contains 700 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Slovenian: En napolnjen injekcijski peresnik vsebuje 700 mikrogramov paratiroidnega hormona (rDNA) v obliki praška v prvi komori in 1000 mikrolitrov vehikla v drugi komori (kar ustreza 14 odmerkom).
English: Each pre-filled pen contains 1050 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Slovenian: En napolnjen injekcijski peresnik vsebuje 1050 mikrogramov paratiroidnega hormona (rDNA) v obliki praška v prvi komori in 1000 mikrolitrov vehikla v drugi komori (kar ustreza 14 odmerkom).
English: Respiratory, thoracic and mediastinal cough disorders Gastrointestinal disorders diarrhoea*
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora kašelj
English: If leaking occurs, call Shire at +44 (0)800 055 6614 for help.
Slovenian: Če imate pomisleke, pokličite družbo Shire na +44 (0)800 055 6614.
English: Each dose contains 75 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 75 mikrogramov paratiroidnega hormona v 71,4 mikrolitra raztopine.
English: Each pre-filled pen contains 1400 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Slovenian: En napolnjen injekcijski peresnik vsebuje 1400 mikrogramov paratiroidnega hormona (rDNA) v obliki praška v prvi komori in 1000 mikrolitrov vehikla v drugi komori (kar ustreza 14 odmerkom).
English: Each dose contains 75 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 75 mikrogramov paratiroidnega hormona (rDNA) v 71,4 mikrolitra raztopine.
English: • muscle twitching or cramping
Slovenian: • trzanje mišic ali mišični krči
English: Natpar 25 micrograms/dose
Slovenian: Natpar 25 mikrogramov/odmerek vijolična oznaka na peresniku
English: Each dose contains 25 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 25 mikrogramov paratiroidnega hormona v 71,4 mikrolitra raztopine.
English: Urolithiasis
Slovenian: Urolitiaza
English: Each dose contains 50 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 50 mikrogramov paratiroidnega hormona v 71,4 mikrolitra raztopine.
English: Hepatic impairment
Slovenian: • mišični krči
English: Each dose contains 25 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 25 mikrogramov paratiroidnega hormona (rDNA) v 71,4 mikrolitra raztopine.
English: Each dose contains 50 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Slovenian: Po rekonstituciji en odmerek vsebuje 50 mikrogramov paratiroidnega hormona (rDNA) v 71,4 mikrolitra raztopine.
English: Do not use this medicine if it has become cloudy, coloured,
Slovenian: Zdravila ne uporabljajte, če je postalo motno, je drugačne barve ali vsebuje vidne delce.
English: Talk to your doctor or pharmacist before using Natpar if you suffer from kidney stones.
Slovenian: Če imate ledvične kamne, se pred začetkom uporabe zdravila Natpar posvetujte z zdravnikom ali farmacevtom.
English: Figure V
Slovenian: Slika V
English: It is also approved in Norway and Iceland.
Slovenian: Odobren je tudi na Norveškem in Islandiji.
English: It was subsequently authorised by Mutual Recognition Procedure in all EU Member States except Ireland.
Slovenian: Nato je bil s postopkom medsebojnega priznavanja odobren v vseh državah članicah, razen na Irskem.
English: The Rapporteur and Co-Rapporteur appointed were Dr. Julia Dunne and Dr. Ingemar Persson, respectively.
Slovenian: Poročevalec in soporočevalec sta bila dr. Julia Dunne in dr. Ingemar Persson.
English: The Member States competent authorities will continue to keep the product under regular review.
Slovenian: Pristojne oblasti držav članic bodo zdravilo še naprej redno nadzorovale.
English: Oral explanations were given on 22 March 2006.
Slovenian: Ustna pojasnila so bila podana dne 22. marca 2006.
English: The final opinion was converted into a Decision by the European Commission on 29 May 2006.
Slovenian: Končno mnenje je bilo spremenjeno v Odločbo Evropske komisije dne 29. maja 2006.
English: Written explanations were provided by the Marketing Authorisation Holder by 30 June 2005, 15 July 2005, 19 July 2005, 20 December 2005 and 7 March 2006.
Slovenian: Imetnik dovoljenja za promet z zdravilom je pisna pojasnila predložil dne 30. junija 2005, 15. julija 2005, 19. julija 2005, 20. decembra 2005 in 7. marca 2006.
English: SUMMARY INFORMATION ON REFERRAL OPINION PURSUANT TO ARTICLE 31 OF COUNCIL DIRECTIVE 2001/83/EC, AS AMENDED, FOR
Slovenian: POVZETEK INFORMACIJ O MNENJU V ZVEZI Z NAPOTITVIJO V SKLADU S ČLENOM 31 DIREKTIVE SVETA 2001/83/ES, KOT JE BILA SPREMENJENA, ZA
English: The referral procedure started on 21 April 2005.
Slovenian: Napotitveni postopek se je začel 21. aprila 2005.
English: Elidel and associated names (See Annex 1)
Slovenian: Elidel in z njim povezana imena (glejte Dodatek I)
English: International Non-Proprietary Name (INN): pimecrolimus
Slovenian: Mednarodno nelastniško ime (INN): pimekrolimus
English: On 21 April 2005, Denmark presented a referral to the EMEA under Article 31 of Directive 2001/83, as amended.
Slovenian: Dne 21. aprila 2005 je Danska na EMEA predložila napotitev v skladu s členom 31 Direktive 2001/83, kot je bila spremenjena.
English: Pimecrolimus was first authorised in the EU in Denmark on 15 March 2002.
Slovenian: Pimekrolimus je bil v EU najprej odobren na Danskem, in sicer 15. marca 2002.
English: London, 29 May 2006 EMEA/262776/2005
Slovenian: EMEA/262776/2006
English: * Note: The information given in this document and Annexes reflect only the CHMP Opinion dated 23 March 2006.
Slovenian: *Opomba: Informacije, podane v tem dokumentu in Dodatkih, odražajo samo mnenje CHMP z dne 23. marca 2006.
English: Pimecrolimus is a calcineurin inhibitor approved as cream formulation at a 1% concentration.
Slovenian: Pimekrolimus je zaviralec kalcineurina in je bil kot zdravilo odobren v obliki kreme v 1 % koncentraciji.
English: On the grounds of safety and efficacy, the CHMP was of the opinion that pimecrolimus should be limited to second line use.
Slovenian: Na podlagi varnosti in učinkovitosti je bil CHMP mnenja, da bi uporaba pimekrolimusa morala biti omejena na zdravljenje druge izbire.
English: The CHMP recommended the restriction of use to these patients where treatment with topical corticosteroids is either inadvisable or not possible.
Slovenian: CHMP je priporočil, da ga uporabljajo le tisti bolniki, pri katerih zdravljenje z lokalnimi kortikosteroidi bodisi ni priporočljivo bodisi ni mogoče.
English: Pimecrolimus was initially approved for the use in patients with mild to moderate atopic dermatitis aged 2 years and over for short-term treatment of signs and symptoms and intermittent long-term treatment for prevention of progression to flares.
Slovenian: Pimekrolimus je bil najprej odobren za uporabo pri bolnikih z blagim do zmernim atopičnim dermatitisom, starih dve leti ali več, za kratkotrajno zdravljenje znakov in simptomov in za dolgotrajno zdravljenje z vmesnimi presledki za preprečevanje širjenja obolenja.
English: The reasons for referral concerned a review of the benefit/risk profile of medicinal products containing pimecrolimus considering efficacy and safety concerns with regards to the potential risk of cancer.
Slovenian: Razlogi za napotitev so bili v zvezi s pregledom razmerja med koristmi in tveganji za zdravila, ki vsebujejo pimekrolimus upoštevajoč pomisleke glede učinkovitosti in varnosti v zvezi s potencialnim tveganjem za raka.
English: Based on evaluation of the available data and the Rapporteurs' assessment reports, the CHMP considered that the benefit/risk profile of pimecrolimus containing medicinal products remains favourable, and therefore adopted an opinion on 23 March 2006 recommending the maintenance of the Marketing Authorisations with amendments to the Summary of Product Characteristics, Labelling and Package Leaflet for pimecrolimus containing medicinal products.
Slovenian: Na podlagi vrednotenja dosegljivih podatkov in poročevalčevega poročila o oceni je CHMP menil, da razmerje med koristmi in tveganji zdravil, ki vsebujejo pimekrolimus, ostaja ugodno in je zato dne 23. marca 2006 sprejel mnenje, v katerem priporoča ohranitev dovoljenja za promet z dopolnitvami Povzetka glavnih značilnosti zdravila, označevanja in Navodil za uporabo za zdravila, ki vsebujejo pimekrolimus.
English: The list of product names concerned is given in the Annex I. The scientific conclusions are provided in the Annex II, together with the amended Summary of Product Characteristics, Labelling and Package Leaflet in the Annex III and the conditions of the marketing authorisations in the Annex IV.
Slovenian: Seznam zadevnih imen zdravil je naveden v Dodatku I. Znanstveni zaključki so podani v Dodatku II, skupaj z dopolnjenim Povzetkom glavnih značilnosti zdravila, označevanjem in Navodili za uporabo v Dodatku III ter pogoji dovoljenja za promet z zdravilom v Dodatku IV.
English: This overview was last updated in May 2018.
Slovenian: Pregled je bil nazadnje posodobljen maja 2018.
English: It should be used after careful evaluation of alternative treatment options;
Slovenian: Uporabi se lahko po skrbni oceni alternativnih možnosti zdravljenja;
English: These side effects are mild and generally short-lived.
Slovenian: Ti neželeni učinki so blagi in na splošno kratkotrajni.
English: Further information on Pexion can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Slovenian: Nadaljnje informacije za zdravilo Pexion so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Epilepsy is caused by excessive electrical activity in the brain.
Slovenian: Epilepsija je posledica prekomerne električne dejavnosti v možganih.
English: • reduce anxiety and fear associated with noise phobia.
Slovenian: • zmanjševanje tesnobe in strahu, povezanih s fobijo zaradi hrupa.
English: The European Medicine Agency decided that Pexion's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je odločila, da so koristi zdravila Pexion večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: Pexion received a marketing authorisation valid throughout the EU on 25 February 2013.
Slovenian: Zdravilo Pexion je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 25. februarja 2013.
English: This may also help in controlling seizures.
Slovenian: To lahko prav tako pomaga pri obvladovanju epileptičnih napadov.
English: The dose is calculated according to the dog's weight.
Slovenian: Odmerek se izračuna na podlagi telesne mase psa.
English: Pexion is a veterinary medicine used in dogs to:
Slovenian: Pexion je zdravilo za uporabo v veterinarski medicini, ki se uporablja pri psih za:
English: Other information about Pexion
Slovenian: Druge informacije o zdravilu Pexion
English: Why is Pexion authorised in the EU?
Slovenian: Zakaj je zdravilo Pexion odobreno v EU?
English: To prevent accidental ingestion, the bottle cap should be replaced immediately after withdrawing the required number of tablets for one dose.
Slovenian: Da se prepreči nenamerno zaužitje, je treba zamašek na steklenico namestiti nazaj takoj, ko se iz nje vzame število tablet, potrebno za en odmerek.
English: Imepitoin also has a weak blocking effect on calcium channels.
Slovenian: Poleg tega ima imepitoin šibek zaviralni učinek na kalcijeve kanalčke.
English: In case of accidental ingestion, especially by a child, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Slovenian: V primeru nenamernega zaužitja zdravila, zlasti pri otrocih, se je treba takoj posvetovati z zdravnikom in mu pokazati navodila za uporabo ali nalepko.
English: 25% of dogs did not respond to Pexion treatment and had the same or an increased number of seizures.
Slovenian: 25 % psov se na zdravljenje z zdravilom Pexion ni odzvalo in so doživeli enako ali večje število napadov.
English: Neurotransmitters such as GABA are chemicals that allow nerve cells to communicate with each other.
Slovenian: Živčni prenašalci, kot je GABA, so kemične snovi, ki omogočajo medsebojno sporazumevanje živčnih celic.
English: These are pores which let calcium move into the nerve cells allowing electrical impulses to be transmitted between nerve cells.
Slovenian: To so pore, ki omogočajo vstopanje kalcija v živčne celice, s čimer se omogoči prenos električnih impulzov med živčnimi celicami.
English: • reduce the frequency of generalised seizures (fits affecting most or all of the brain) due to epilepsy of unknown causes (idiopathic).
Slovenian: • zmanjševanje pogostnosti generaliziranih epileptičnih napadov (krčev, ki prizadenejo večji del možganov ali celotne možgane) pri epilepsiji neznanega izvora (idiopatski).
English: What are the risks associated with Pexion?
Slovenian: Kakšna tveganja so povezana z zdravilom Pexion?
English: An overview of Pexion and why it is authorised in the EU
Slovenian: Pregled zdravila Pexion in zakaj je odobreno v EU
English: Imepitoin's effect on GABA receptors also reduces fear and anxiety.
Slovenian: Delovanje imepitoina na receptorje GABA prav tako zmanjša strah in tesnobo.
English: What is Pexion and what is it used for?
Slovenian: Kaj je zdravilo Pexion in za kaj se uporablja?
English: What benefits of Pexion have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Pexion izkazalo v študijah?
English: For the full list of side effects and restrictions of Pexion, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Pexion glejte navodilo za uporabo.
English: Pexion must not be used in dogs with severely impaired liver, kidney or heart function.
Slovenian: Zdravilo Pexion se ne sme uporabljati pri psih s hudo okvaro jeter, ledvic ali srca.
English: If seizures are not adequately controlled after one week, the veterinary surgeon may increase the dose by 50 - 100% at a time, to a maximum of 30 mg per kg bodyweight twice a day.
Slovenian: Če se napadi po enem tednu ustrezno ne zmanjšajo, lahko veterinar odmerek povečuje po 50100 % naenkrat do največjega odmerka 30 mg na kilogram telesne mase dvakrat na dan.
English: Even though the proportion of seizure-free dogs was lower with Pexion than with phenobarbital, some dogs were well-controlled with Pexion.
Slovenian: Čeprav je bil delež psov brez napadov pri zdravilu Pexion nižji kot pri fenobarbitalu, so bili nekateri psi dobro nadzorovani s tem zdravilom.
English: The effectiveness of Pexion to treat dogs with status epilepticus and cluster seizures has not been studied.
Slovenian: Učinkovitost zdravila Pexion pri zdravljenju psov z epileptičnim statusom in serijskimi epileptičnimi napadi ni bila raziskana.
English: By activating its receptors, imepitoin increases GABA's effects and helps to prevent seizures.
Slovenian: Imepitoin z aktiviranjem receptorjev poveča učinke živčnega prenašalca GABA in pomaga preprečiti epileptične napade.
English: As side-effects were less frequent than with phenobarbital, Pexion is a suitable treatment option for some dogs, considering in particular its safety profile.
Slovenian: Ker so bili neželeni učinki manj pogosti kot pri fenobarbitalu, je zdravilo Pexion zlasti zaradi svojega varnostnega profila primerna možnost zdravljenja za nekatere pse.
English: Pexion is available as tablets and can only be obtained with a prescription.
Slovenian: Zdravilo Pexion je na voljo v obliki tablet, predpisovanje in izdaja zdravila pa je le na recept.
English: Imepitoin partially activates the receptors for the neurotransmitter GABA, a substance that reduces electrical activity in the brain.
Slovenian: Imepitoin v možganih delno zavira receptorje za živčni prenašalec GABA, tj. snov, ki zmanjšuje električno dejavnost v možganih.